Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$24.35 - $44.39 $9,959 - $18,155
409 Added 1.78%
23,400 $569,000
Q1 2024

Apr 16, 2024

BUY
$31.23 - $42.99 $8,963 - $12,338
287 Added 1.26%
22,991 $776,000
Q4 2023

Feb 05, 2024

BUY
$17.71 - $32.97 $6,694 - $12,462
378 Added 1.69%
22,704 $715,000
Q3 2023

Oct 13, 2023

BUY
$25.44 - $37.35 $567,973 - $833,876
22,326 New
22,326 $570,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $478M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Summer Haven Investment Management, LLC Portfolio

Follow Summer Haven Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summer Haven Investment Management, LLC with notifications on news.